Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Mtg: My read

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
LOL83001 Member Profile
 
Followed By 2
Posts 237
Boards Moderated 0
Alias Born 05/29/19
160x600 placeholder
Activist investor group pushing for CytoDyn board overhaul Seeking Alpha - 7/28/2021 9:36:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2021 5:26:03 PM
Proxy Statement - Contested Solicitations (preliminary) (prec14a) Edgar (US Regulatory) - 7/20/2021 5:06:54 PM
CytoDyn to hold webcast on July 22 to discuss cancer, NASH, and COVID-19 trials Seeking Alpha - 7/20/2021 12:01:04 AM
CytoDyn reports preliminary leronlimab results from mid-stage breast cancer study Seeking Alpha - 7/19/2021 6:19:22 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/12/2021 6:31:24 PM
CytoDyn advances leronlimab into Phase 2 stage in breast cancer trial Seeking Alpha - 7/12/2021 7:10:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2021 5:12:45 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 7/7/2021 4:17:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:31:55 PM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
CytoDyn submits dose justification report to FDA for leronlimab BLA in HIV Seeking Alpha - 7/2/2021 1:55:53 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 7/1/2021 5:28:14 PM
CLNV Targets $300 Billion Food Packaging Industry With Environmentally Sustainable Biodegradable Alternative InvestorsHub NewsWire - 6/22/2021 9:55:37 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
CytoDyn posts preliminary results from COVID-19 long-haulers study Seeking Alpha - 6/21/2021 9:38:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2021 5:01:59 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/8/2021 4:32:22 PM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
CytoDyn's partner to submit request to conduct Phase 3 leronlimab studies in Brazil Seeking Alpha - 5/27/2021 6:33:58 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/24/2021 5:16:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 5:18:50 PM
CytoDyn promotes Antonio Migliarese to CFO role Seeking Alpha - 5/20/2021 5:14:56 PM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
CytoDyn to submit CD12 trial data to regulatory agencies in multiple countries Seeking Alpha - 5/18/2021 7:45:54 AM
LOL83001   Wednesday, 07/22/20 01:28:31 PM
Re: None
Post # of 176312 
Mtg: My read
>Resolutions both passed - 100M - 65% ; Adjourn Spec Mtg- 67%
>Nice letter from shareholder read- "keep up the good work, don't get tired."
> Amorphous NP ramble about past dilution and comparative enrollment in clinicals.
>Yada Yada on limiting dilution - only diluted 15M shares in 2020 so far. (with SP up 20x in 6 months - frankly who gives a sh8t about 15% dilution)
>NP: Hoopin & hollerin about good sh*t happening.
Kelly: Good stuff happening, crisp clean and to me incomprehensible biochem mechanism discussion
> Mulholan: We are well into week 2 of what usually is a 6 week uplist process. All rocking along. Next move is NASDQ nit-pick letter he expects to get next week... prepared to turn that around fast.
>Kelly: read out Science Advisory Board and some CV's. Impressive gang.
>NP: More about how the M2M P2 safety data is super positive. (If you don't get that think this: With Pro-140 you had lots less AE & SAE, thus you are better off. ) Efficacy data coming, but to me this looks damn good.
>Lots of tech difficulty. This is Comptershare issue- I guess they have to have secure voting capability so had to use that wonky software.







Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences